COMMITMENTS AND CONTINGENCIES (Details Narrative)	10 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of share options exercised value	$ 25,000	[1]
Shares price per share | $ / shares	$ 1.28
Representative shares value	$ 132,480
Representative shares issued | shares	103,500
Permanent shareholders equity	$ 132,480
Underwriters [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share price | $ / shares	$ 0.30
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of stock price per share | $ / shares	$ 10.00
Deferred underwriting fees	$ 3,450,000
Shares price per share | $ / shares	$ 10.25
IPO [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares of stock issued | shares	103,500
IPO [Member] | Underwriters [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of stock price per share | $ / shares	$ 10.00
Number of share options exercised value	$ 15,000,000
Share price | $ / shares	$ 0.11
Proceeds from initial public offering	$ 1,265,000
Deferred underwriting fees	$ 3,450,000
Underwriting Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of share options exercised | shares	1,500,000

[1] Includes up to 643,777 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). The underwriters exercised their over-allotment option in full on February 14, 2023; thus, no ordinary shares remain subject to forfeiture as of February 14, 2023 (see Note 6).